Diabetes Mellitus as a Predictor for Radial Artery Vasoreactivity in Patients Undergoing Coronary Artery Bypass Grafting  by Choudhary, Bikram P. et al.
R
e
r
W
n
w
m
i
f
d
F
U
c
a
Journal of the American College of Cardiology Vol. 50, No. 11, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PCardiac Surgery
Diabetes Mellitus as a Predictor for
Radial Artery Vasoreactivity in Patients
Undergoing Coronary Artery Bypass Grafting
Bikram P. Choudhary, MRCS,* Charalambos Antoniades, MD, PHD,† Alison F. Brading, PHD,‡
Antony Galione, PHD,‡ Keith Channon, MD, FRCP,† David P. Taggart, MD, PHD, FRCS*
Oxford, United Kingdom
Objectives Our purpose was to examine the impact of diabetes mellitus (DM) on vasoreactivity and endothelial function of
radial artery (RA) grafts ex vivo.
Background The arteriopathy associated with DM may influence the surgeon’s choice of conduits for revascularization.
Arterial conduits and especially the RA are prone to vasospasm in the perioperative period.
Methods The study population consisted of 98 patients with coronary artery disease undergoing coronary artery bypass
grafting by using RA grafts. The maximum contractions of RA segments induced by K (66 mmol/l) and clini-
cally important vasoconstrictors such as adrenaline (5  105 mol/l), angiotensin II (106 mol/l), and prosta-
glandin F2 (PGF2) (106 mol/l) were recorded. Relaxation of RA rings to carbachol (104 mol/l) was used as
a measure of endothelial function. Multivariate analysis was then applied to determine the role of clinical char-
acteristics on the vasomotor responses to these agents.
Results Vessels from patients with DM had greater contractions in response to adrenaline (p  0.05), angiotensin (p 
0.05), and PGF2 (p  0.01) compared with non-DM vessels, despite the similar vasoconstrictions induced by
high K (p  NS). Diabetes mellitus was also associated with smaller vasorelaxations in response to carbachol
(p  0.001). In multivariate analysis, DM was an independent predictor of RA contractions in response to adren-
aline ( [SE] 3.085 [1.410], p  0.031), angiotensin II ( [SE] 3.838 [1.552], p  0.015), and PGF2 ( [SE]
4.609 [1.908], p  0.018) but not K (p  NS). Diabetes mellitus was also independently associated with the
vasorelaxations in response to carbachol ( [SE] 15.645 [2.622], p  0.0001).
Conclusions Diabetes mellitus is associated with impaired endothelial function and greater contractions of RA grafts in re-
sponse to all of the clinically relevant vasoconstrictors. These findings suggest that the RA of diabetic patients
may be more prone to spasm in response to endogenous vasoconstrictors, an observation with important impli-
cations for surgeons’ choice of conduits in this cohort of patients. (J Am Coll Cardiol 2007;50:1047–53)
© 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.06.008c
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becent advances in percutaneous interventions have mark-
dly influenced the demographic profile of patients being
eferred for coronary artery bypass grafting (CABG) (1).
hereas percutaneous coronary intervention has made sig-
ificant inroads in the revascularization of patients with
ell-defined and discrete coronary lesions, patients with
ore diffuse coronary artery disease (CAD) still do signif-
cantly better in terms of survival and reduced need for
urther intervention with CABG (2,3). Coronary artery
isease is common in adults with diabetes mellitus (DM)
rom the *Department of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford,
nited Kingdom; and the Departments of †Cardiovascular Medicine and ‡Pharma-
ology, University of Oxford, Oxford, United Kingdom.s
Manuscript received February 28, 2007; revised manuscript received May 2, 2007,
ccepted June 3, 2007.ompared with nondiabetic patients and carries a worse
rognosis (4). As the incidence of DM continues to rise
orldwide and as CAD in diabetic patients tends to be
ore aggressive and diffuse in nature (5), these patients
ake up an ever-increasing proportion of the surgical
ohort.
Diabetic patients are at increased risk of mortality and
orbidity after any form of coronary revascularization (4,6),
nd a meticulous surgical strategy is therefore mandatory. The
nternal mammary artery is especially resistant to arteriosclero-
is and, even in diabetic patients, has an established long-term
atency and survival advantage over either saphenous vein or
adial artery (RA) grafts (7,8). There is also evidence to suggest
hat diabetic patients do better with more arterial grafts (7,9),
ut this must be counterbalanced against the increased risks of
ternal wound complications in these patients (10).
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the RA is the third most com-
monly used conduit in CABG
(11), and reported patency data
suggest that it has at least as good
patency in the short-to-medium
term as saphenous vein grafts and
may be possibly superior in the
long term (8,12). Early RA graft
spasm is reported to occur in up
to 10% of patients after CABG
and may lead to perioperative
myocardial infarction or death
(11). Longer-term RA graft pa-
tency is now known to be signif-
icantly affected by the caliber of
nd the degree of stenosis in the native coronary vessel and
he quality of distal run off (13). Furthermore, RAs from
iabetic patients are more prone to calcium deposition,
hich may make the conduit unusable in many of these
atients (14).
Diabetes mellitus is associated with endothelial dysfunc-
ion (15,16), but it is unknown whether diabetic patients are
ore or less prone to RA vasospasm compared with
ondiabetic subjects in the perioperative period, and what
ffect this may have on longer-term graft patency. Using
unctional myography, we sought to examine whether DM
as any effect on the tendency for RA vasospasm in CABG
atients, by determining the vasomotor responses of RA
rafts to several endogenous vasoconstrictors such as adren-
line, angiotensin II, and prostaglandin F2 (PGF2). To
urther investigate the underlying mechanisms of this effect,
e examined whether the potential effects of DM on the
asoconstrictive responses of RA to endogenous vasocon-
trictors were due to a direct impairment of endothelial
unction.
ethods
tudy protocol and population. The study population
onsisted of 98 patients undergoing elective CABG in the
ohn Radcliffe Hospital, Oxford, United Kingdom
Table 1). Diabetes mellitus was defined in accordance with
he National Data Group Criteria (17). Exclusion criteria
ere evidence for hepatic or hematologic abnormalities,
resence of inflammatory or renal disease, as well as acute
oronary event during the last 3 months before recruitment.
During the recruitment period, all patients scheduled for
ABG by using RA grafts, who fulfilled the inclusion
riteria and agreed to participate, were recruited for the
tudy. To examine the effect of DM on the vasomotor
esponses of RA grafts, we recruited 75 nondiabetic and 23
iabetic patients (with glycosylated hemoglobin [HbA1c]
.45  0.18%). Nondiabetic subjects were matched to
iabetic patients according to age, gender, and classic risk
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
CAD  coronary artery
disease
DM  diabetes mellitus
HbA1c  glycosylated
hemoglobin
NO  nitric oxide
PGF2  prostaglandin F2
PSS  physiological saline
solution
RA  radial arteryactors for atherosclerosis (Table 1); they had HbA1c a6.0%, body mass index 29.9 kg/m2, and no clinical
vidence of insulin resistance. The study was approved by
he Oxfordshire Research Ethics Committee (OXREC
umber CA0129), and patients who gave informed written
onsent were enrolled.
pecimen collection and preparation. Radial artery con-
uits were harvested, as previously described (18,19), using
longitudinal forearm incision, and careful dissection of the
rtery and its pedicle with scissors, clips, and diathermy.
adial arteries with any evidence of macroscopic calcifica-
ion were rejected and not included in the study. After
arvesting, a 1- to 2-cm segment of the most distal portion
f the RA was immediately placed in chilled (4°C) physio-
ogical saline solution (PSS) and transferred to the labora-
ory on ice where fat and periarteriolar connective tissue was
emoved. The vessel was divided into four 2- to 3-mm rings
nd mounted on steel wires in a multichamber automated
yograph (Danish Myo Ltd., Winston-Salem, North
arolina). The rings were allowed to equilibrate for 60 min
n aerated PSS (95% O2, 5% CO2) at 37°C. Throughout
reparation and mounting, strenuous efforts were made to
inimize any potential trauma to the vascular endothelium.
xperimental protocol. The experimental protocol has
een previously described in detail (18,19). Briefly, after the
quilibration and mounting process (see the preceding text),
emographic Characteristics of the Participants
Table 1 Demographic Characteristics of the Participants
Nondiabetic Patients Diabetic Patients
Age (yrs) 62.7 0.78 58.5 1.9
Weight (kg) 80.13 1.38 81.8 3.3
Body mass index (kg/m2) 25.9 0.36 28.48 0.98*
Gender (male/female) 60/15 15/8
Recent smoking (%) 42 (56%) 11 (48%)
Hypertension (%) 61 (81%) 18 (78%)
Hypercholesterolemia (%) 50 (66%) 16 (69%)
Number of grafts used*
2 24 2
3 51 16
4 — 4
5 — 1
Insulin-dependent DM — 10
Years since diagnosis of DM — 10.8 1.06
Medication
Aspirin 75 23
Beta-blockers 26 11
Statins 75 23
ACEi 35 19
Diuretics 32 7
CCB 22 5
Insulin — 10
Sulfonylureas — 10
Biguanides — 6
Insulin sensitizers — 2
alues are expressed as mean SEM. *p 0.01 for diabetic patients versus nondiabetic patients.
ACEi  angiotensin-converting enzyme inhibitors; CCB  calcium channel blockers; DM 
iabetes mellitus.resting tension of 3 g (approximately equivalent to 100
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September 11, 2007:1047–53 Diabetes Mellitus and Radial Artery Vasoreactivitym Hg arterial pressure) was gradually applied to the RA
ings by slowly lengthening the distance between the
ounting hooks. Once tension had been stabilized, the
ings were kept at this same length throughout the experi-
ent. The incubating PSS was then replaced with iso-
smolar high K PSS (containing 66 mmol/l KCl) to test
iability and to produce a controlled contraction. The rings
ere then washed with PSS to allow relaxation to baseline
efore being contracted again with either high K PSS,
GF2 (106 mol/l), adrenaline (5  105 mol/l), or
ngiotensin II (106 mol/l); the concentrations of vasocon-
trictors used were predetermined from preliminary exper-
ments (Fig. 1). To avoid any adverse effects from repeated
ontractions and to avoid accumulation of vasoconstrictors
n the chambers of the myograph, each RA ring was only
ontracted with a single vasoconstrictor.
ssessment of endothelial function. The degree of relax-
tion induced by the acetylcholine analogue carbachol (104
ol/l) after precontraction with PGF2 (106 mol/l) was
ecorded and used as a measure of endothelial function.
rugs and solutions. Physiological saline solution was
reshly prepared for each experiment and was composed of
a  137 mmol/l, K 5.9 mmol/l, Mg2 1.2 mmol/l,
a2 2.5 mmol/l, CL 134 mmol/l, H2PO4
 1.2 mmol/l,
CO3
 15.5 mmol/l, and glucose 11.5 mmol/l, pH 7.4.
he following stock solutions of drugs were prepared in
SS and stored in frozen 0.8-ml aliquots: adrenaline (5 
04 mol/l), angiotensin II (104 mol/l), PGF2 (104
ol/l), and carbachol (102 mol/l) (supplied from Sigma-
ldrich Chemicals, Poole, United Kingdom).
tatistical analysis. The result of each experiment was
ogged using Maclab data recording software (ADInstru-
ents, Bella Vista, Australia). Power calculations, based on
reliminary data from our laboratory, showed that a total
umber of 85 patients was able to detect a 20% difference in
Figure 1 Vasoconstrictive Responses of RA Grafts to Endogeno
Dose-response curves of the vasoconstrictive responses of radial artery (RA) grafts
adrenaline (B), and angiotensin II (C) are presented. Values are expressed as mehe vasomotor responses of RA to PGF2 between nondi- mbetic and diabetic patients (3:1 ratio), with   0.05 and
tatistical power 80%. However, we increased the total
umber of patients to 98, to allow for 15% drop-outs. Data
ere tested for normal distribution by using the
olmokorov-Smirnov test. Normally distributed variables
re expressed as means  standard error of the mean, and
on-normally distributed variables (vasomotor responses to
igh K) were log-transformed for all analyses and are
resented in the nonlogarithmic format as median (25th to
5th percentile). The logs of the non-normally distributed
ariable had normal distribution. Comparisons between 2
roups were performed by unpaired t test as appropriate. To
xamine whether DM was an independent predictor of the
asomotor responses of RA to each of the agonists we used,
e performed linear regression by using the maximum
ontractions in response to PGF2, K, adrenaline, or
ngiotensin II or the maximum relaxation in response to
arbachol as dependent variables, and as independent vari-
bles DM and those of the clinical factors (gender, dyslip-
demia, smoking, hypertension, body weight, and age),
hich showed significant correlations with the respective
ependent variable in univariate analysis at 15% significance
evel. A backward elimination procedure was applied in all
ultivariate models (using p  0.05 as the threshold for
emoving a variable from the model, by using the backward
ethod in SPSS software [SPSS Inc., Chicago, Illinois]).
ll the analyses were performed by using SPSS software
ersion 12.0.
esults
he demographic characteristics of the participants are
resented in Table 1. The concentration of each constrictor
as predetermined in a pilot study of 4 patients, using dose
esponse curves (Fig. 1) and selected so as to produce near
asoconstrictors
ostaglandin F2 (PGF2) (A),
SEM.us V
to pr
an aximal contraction. As expected, there were significant
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Diabetes Mellitus and Radial Artery Vasoreactivity September 11, 2007:1047–53orrelations of the vasomotor responses of RA to different
asoconstrictors such as adrenaline, angiotensin II, PGF2,
nd high K. In univariate analysis, the contractions in
esponse to adrenaline were correlated with the contractions
n response to angiotensin II (r  0.339, p  0.001),
GF2 (r  0.332, p  0.001), and high K (r  0.239,
 0.018). Similarly, the contractions in response to
ngiotensin II correlated with the contractions in response
o PGF2 (r  0.732, p  0.0001) and high K (r 
.427, p  0.0001), whereas the contractions in response to
GF2 also correlated with the contractions in response to
igh K (r  0.570, p  0.0001).
Figure 2 The Effect of DM on the Responses
of RA Grafts to Endogenous Vasoconstrictors
Radial artery (RA) from patients with diabetes mellitus (DM) had significantly
greater vasomotor responses to adrenaline, angiotensin II, and prostaglandin
F2 (PGF2) compared with nondiabetic patients. Values are expressed as
mean  SEM.
Figure 3 The Effect of DM on the Vasoconstrictions of RA Graf
Response to High K and the Vasorelaxations in Res
(A) There was no difference in radial artery (RA) contractions in response to high K
Values are expressed as median (25th to 75th percentile) and range. (B) The RA
mol/l) compared with nondiabetic patients. Values are expressed as mean  SEMM and vasomotor responses of RA grafts. Radial artery
rafts from patients with DM appeared to have significantly
reater vasomotor responses to adrenaline, PGF2, and
ngiotensin II (Fig. 2). However, there was no significant
ifference in the vasomotor responses of RA to high K
etween patients with DM (median [25th to 75th percen-
ile] 13.05 g [7.78 to 21.07 g]) and patients without DM
median [25th to 75th percentile] 11.91 g [7.37 to 20.88 g],
 NS) (Fig. 3A).
Body mass index was also correlated in univariate analysis
ith the vasomotor responses to all the examined vasocon-
trictors (adrenaline [r  0.353, p  0.0001], PGF2 [r 
.312, p  0.002], angiotensin II [r  0.366, p  0.0001],
ncluding high K [r  0.290, p  0.004]).
Carbachol (104 mol/l) induced a significantly lower
asorelaxation in PGF2 (106 mol/l) precontracted RA
ings from patients with DM compared with nondiabetic
atients (Fig. 3B). However, the vasorelaxations in response
o carbachol were not correlated with the vasoconstrictive
esponses to K (r  0.052, p  0.614), adrenaline (r 
0.081, p  0.429), angiotensin (r  0.033, p  0.744),
r PGF2 (r  0.038, p  0.708), suggesting that the
ffect of DM on vasomotor responses to endogenous vaso-
onstrictors is independent of its effects on endothelial
unction.
esults from multivariate analysis. In multivariate analy-
is, the only independent predictors for the contractions in
esponse to PGF2 were DM ( [SE] 4.609 [1.908], p 
.018) and body weight ( [SE] 0.162 [0.060], p  0.008).
imilarly, the only independent predictors for the vasomo-
or responses to angiotensin II and adrenaline were DM (
SE] 3.838 [1.552], p  0.015, and  [SE] 3.085 [1.410],
 0.031, respectively) and body weight ( [SE] 0.186
0.051], p  0.0001, and  [SE] 0.168 [0.047], p  0.001,
to CCh
tween patients with diabetes mellitus (DM) and nondiabetic patients (p  NS).
atients with DM had lower relaxations in response to carbachol (CCh) (104ts in
ponse
 be
from p
.
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ody weight was the only independent predictor ( [SE]
.225 [0.063], p 0.001). The only independent predictors
or the vasorelaxations of RA in response to carbachol were
ale gender ( [SE] 6.31 [2.62], p  0.018) and DM (
SE]15.645 [2.622], p 0.0001). Interestingly, the effect
f DM on the vasomotor responses to all the examined
asoconstrictors was independent from the effects on endo-
helial function.
iscussion
n the present study we have demonstrated that RAs
btained from diabetic patients with CAD have greater
endency to spasm compared with RAs from nondiabetic
atients, and that RAs from patients with DM have
mpaired endothelial function. In multivariate analysis,
nly DM and body weight were independent predictors
f the vasomotor responses of RAs to all endogenous
asoconstrictors. Interestingly, the effect of DM on the
asoconstrictive responses of RAs to endogenous agonists
as independent from its effects on endothelial function.
hese findings provide new insights into the complex
echanisms of vasospasm in RA grafts, suggesting that
M may induce vasospasm in RA grafts by acting
irectly to the vascular wall, independently from its
ffects on vascular endothelium.
ascular endothelium and vasospasm in RAs. Evidence
uggests that substances such as angiotensin II (20), cat-
cholamines, and PGF2 (21) are the main endogenous
asoconstrictors responsible for the spasm of RA grafts
uring the early postoperative period. The circulating levels
f many of these substances are increased during and after
ardiac surgery (22), and their direct effects on RA graft
egments ex vivo are used as a reliable model system to
xamine the mechanisms of vasospasm in these grafts (19).
owever, the propensity of these grafts toward spasm is not
olely a function of the muscular wall, but endothelium-
erived nitric oxide (NO), as a major vasorelaxant in human
asculature (23), may also be implicated into this phenom-
non (24).
In the present study we examined whether the ex vivo
asomotor responses of RA grafts to endogenous vasocon-
trictors such as angiotensin II, PGF2, and adrenaline are
orrelated with the vasorelaxations induced by a NO-
eceptor–mediated vasorelaxant, carbachol. Surprisingly, the
asorelaxations in response to carbachol were not correlated
ith the vasomotor responses to any of the vasoconstrictive
gents, implying that NO may not be a major modulator of
he vasoconstrictive responses of RA grafts to adrenaline,
GF2, or angiotensin II. On the contrary, a direct effect of
hese vasoconstrictors on the vascular wall is more likely to
e responsible for their vasospastic effect on these grafts.
M and vasospasm in RAs. Smooth muscle function in
atients with DM is still an unresolved issue. There is
ompelling evidence for increased production of vasocon- utrictors such as angiotensin II, endothelin 1, cyclooxygen-
se, and lipoxygenase products of arachidonic acid metab-
lism in diabetic vessels (25). These molecules as well as
ther cytokines and growth factors that increase vascular
one seem to contribute to the microvascular, macrovascular,
nd renal complications in diabetes. There is also evidence
o suggest that patients with long-standing DM have
mpaired vasoreactivity, which may be attributable to higher
evels of calcification in the vessel wall (14). The increased
evels of endogenous vasoconstrictors combined with the
mpairment of vascular smooth muscle cells in arteries from
atients with DM (23) lead to the hypothesis that the whole
rterial tree in DM may be more prone to vasospasm.
owever, it is unknown whether RA from diabetic patients
sed as CABG grafts have higher incidence of spasm
ompared with RA from nondiabetic patients.
In the present study we have demonstrated that RA grafts
rom patients with DM have impaired endothelial function
nd are more prone to vasospasm. These findings are
ompatible with previous reports showing that diabetic
essels are more prone to vasoconstriction, but this is still a
opic of controversy (26–28). Although extrapolation of our
ndings would suggest that RAs from diabetic patients may
e more prone to early occlusion than RAs from nondiabetic
atients, the recently reported interim results of RAPS
Radial Artery Patency Study), a randomized trial compar-
ng radial and saphenous vein graft patency using angio-
raphic follow-up, failed to show diabetes as an indepen-
ent risk factor for RA occlusion at 1-year follow-up (12).
herefore, we hypothesize that the increased RA contrac-
ility seen in vessels from diabetic patients may lead to an
ncreased incidence of immediate postoperative RA spasm
nd perioperative ischemia/infarction without directly im-
acting on short-to-medium-term patency.
Another finding of the present study was the association
etween body mass index (or body weight) and the vaso-
onstrictions in response to all the agents used, including
igh K. One could speculate that patients with higher body
eight are more likely to have more muscular RA grafts,
eading to a nonspecific association between body mass index
or body weight) and the vasoconstrictive responses. Impor-
antly, these associations were independent of the presence of
M, as it was demonstrated in multivariate analysis. In any
ase, this is a finding requiring further exploration.
It is likely that the decreased NO bioavailability in vessels
rom patients with DM may affect vasoreactivity, because
ndothelium-derived NO is a major vasorelaxant in human
asculature (23). Indeed, diabetes-induced impairment of
ndothelial function is a systemic phenomenon (23,29)
bserved in the brachial artery (30), the coronaries (31), as
ell as in vessels used as grafts in CABG, such as internal
ammary arteries (23) and saphenous veins (32). Endothe-
ial dysfunction in DM is multifactorial in nature, including
ecreased NO synthesis (33) and increased NO breakdown
ue to the higher oxidative stress status (34,35). In partic-
lar, evidence suggests that in vessels from diabetic patients,
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Diabetes Mellitus and Radial Artery Vasoreactivity September 11, 2007:1047–53ndothelial NO synthase is largely “uncoupled” and it is a
ource of superoxide radicals instead of NO (16). Further to
he increased oxidative stress status, other mechanisms such
s the proinflammatory stimuli or the presence of insulin
esistance are also key mechanisms inducing endothelial
ysfunction in diabetic patients (36).
In the present study we confirmed that DM is associated
ith decreased NO bioavailability in RA grafts, from
atients undergoing CABG. However, we have also dem-
nstrated that the vasoconstrictive responses of RA grafts to
ndogenous vasoconstrictors implicated in vasospasm, such
s angiotensin II, PGF2, and adrenaline, are independent
rom NO bioavailability in the same vessels, as determined
y the vasorelaxations in response to carbachol. These
ndings suggest that the stimulatory effect of DM on RA
asospasm is more likely to be due to direct damage of the
ascular wall, including impairment of vascular smooth
uscle cells or vascular innervation, rather than due to the
oexisting decreased NO bioavailability. Indeed, our find-
ngs are compatible with recent reports from animal models,
uggesting increased aortic vasoreactivity in a diabetic rat
odel (37), which may be due to direct effects of DM on
he functional coupling of angiotensin II-angiotensin type 1
eceptors (38) or the increased responsiveness of vascular
mooth muscle cells to catecholamines (37).
A limitation of our study is the absence of any direct
easurement of insulin resistance in the study population.
herefore, the presence of patients with insulin resistance
but without clinically documented DM) among the non-
iabetic group cannot be excluded. Furthermore, ex vivo
easurements of vasorelaxations of RA grafts in response to
arbachol or vasomotor responses to the examined vasocon-
trictors should not be directly extrapolated to in vivo
onditions. Although this is considered to be a good model
ystem to study the properties of these vessels (39) and it
rovides similar results to noninvasive measures of vascular
unction (40), any extrapolation to a clinical setting should
e made with caution because the concentrations of these
asoactive agents used in this model are higher than those
bserved in human circulation in vivo.
onclusions
his is the first study demonstrating that DM is an
ndependent predictor for the vasomotor responses of RA
rafts to physiological vasoconstrictors such as adrenalin,
GF2, and angiotensin II. Furthermore, we provide evi-
ence that endothelial dysfunction also observed in RA
rom diabetic patients is not related to the increased
asomotor responses of these grafts to endogenous vasocon-
trictors. Further prospective clinical data are required to
etermine whether RA is a rather inferior CABG graft type
n diabetic patients, as a result of its higher likelihood for
erioperative spasm.eprint requests and correspondence: Dr. David P. Taggart, Depart-
ent of Cardiothoracic Surgery, John Radcliffe Hospital, Oxford
X3 9DU, United Kingdom. E-mail: david.taggart@orh.nhs.uk.
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